Medicare Enrolled

Dr. Oya Tugal, MD

Pediatric Hematology & Oncology Physician · Hawthorne, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
19 BRADHURST AVE, Hawthorne, NY 10532
9144937997
In practice since 2005 (20 years)
NPI: 1093707838 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Tugal from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Tugal? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Tugal

Dr. Oya Tugal is a pediatric hematology & oncology physician in Hawthorne, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Tugal performed 144 Medicare services across 75 unique beneficiaries.

Between the years covered by Open Payments, Dr. Tugal received a total of $48,463 from 32 pharmaceutical and/or device companies across 188 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pediatric hematology & oncology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Tugal is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 144 Medicare services $48,463 industry payments

Medicare Practice Summary

Medicare Utilization ↗
144
Medicare services
Bottom 45% in NY for pediatric hematology & oncology physician
75
Unique beneficiaries
$107
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~7 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
76 $161 $411
Blood or blood product transfusion
The administration of whole blood or specific blood components into a patient's bloodstream.
40 $37 $108
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
28 $60 $214
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
47.2% high complexity
0.0% medium
52.8% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$48,463
Total received (2018-2024)
Avg $6,923/year across 7 years
Top 7% in NY for pediatric hematology & oncology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
32
Companies
188
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$39,231 (80.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$5,447 (11.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,786 (7.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$6,268
2023
$18,145
2022
$10,081
2021
$11,551
2020
$540
2019
$412
2018
$1,466

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$5,831
Takeda Pharmaceuticals U.S.A., Inc.
$66
CSL Behring
$65
IRONSHORE PHARMACEUTICALS INC.
$63
GENZYME CORPORATION
$53
USWM, LLC
$31
Alexion Pharmaceuticals, Inc.
$27
SOBI, INC
$27
Genentech USA, Inc.
$24
SERVIER PHARMACEUTICALS LLC
$23
Biocon Biologics Inc
$23
Grifols USA, LLC
$19
Agios Pharmaceuticals, Inc.
$18
Top 3 companies account for 95.1% of 2024 payments
All-time payments by company (2018-2024) ›
Global Blood Therapeutics, Inc.
$15,384
Octapharma USA, Inc.
$14,446
PFIZER INC.
$11,810
CSL Behring
$3,505
Ironwood Pharmaceuticals, Inc
$705
Alexion Pharmaceuticals, Inc.
$361
Amgen Inc.
$311
Novartis Pharmaceuticals Corporation
$238
Astellas Pharma US Inc
$198
Genentech USA, Inc.
$173
Grifols USA, LLC
$171
GENZYME CORPORATION
$163
Takeda Pharmaceuticals U.S.A., Inc.
$153
Alnylam Pharmaceuticals Inc.
$148
Shire North American Group Inc
$141
SANOFI-AVENTIS U.S. LLC
$91
IRONSHORE PHARMACEUTICALS INC.
$63
SOBI, INC
$49
Sobi, Inc
$45
SERVIER PHARMACEUTICALS LLC
$44
Bio Products Laboratory USA, Inc.
$39
Aveo Pharmaceuticals, Inc.
$32
USWM, LLC
$31
Ironshore Pharmaceuticals Inc.
$26
Biocon Biologics Inc
$23
Allergan Inc.
$20
Jazz Pharmaceuticals Inc.
$18
Agios Pharmaceuticals, Inc.
$18
Novo Nordisk Inc
$17
BIOVERATIV THERAPEUTICS INC.
$15
Dova Pharmaceuticals
$14
Bayer HealthCare Pharmaceuticals Inc.
$11
Top 3 companies account for 85.9% of all-time payments
Associated products mentioned in payments ›
ADVATE · ADYNOVATE · ALPROLIX · ALTUVIIIO · Afstyla · Alphanate · Asparlas · BENEFIX · Blincyto · Coagadex · Doptelet · ELOCTATE · Erwinaze · Esperoct · FOTIVDA · Fulphila · GAMIFANT · GIVLAARI · GIVLARRI · Gammaplex · Gamunex-C · HEMGENIX · HEMLIBRA · Haegarda · Hemlibra · IWILFIN · Idelvion · JADENU · JORNAY PM · Jivi · Kcentra · NUWIQ · Nplate · ONCASPAR · OXBRYTA · PANZYGA · PROMACTA · SOLIRIS · TAKHZYRO · ULTOMIRIS · VRAYLAR · WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) · XYNTHA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (81%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pediatric hematology & oncology physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 7% for pediatric hematology & oncology physician in NY.

Looking for a pediatric hematology & oncology physician in Hawthorne?
Compare pediatric hematology & oncology physicians in the Hawthorne area by procedure volume, costs, and industry payment transparency.
Browse pediatric hematology & oncology physicians nearby

Geographic Context

Pediatric hematology & oncology physicians within 10 mi
131
Per 100K population
13.1
County median income
$118,411
Nearest hospital
WESTCHESTER MEDICAL CENTER
1.4 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Tugal is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 7% of NY peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Tugal experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Tugal performed 76 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Tugal receive payments from pharmaceutical companies?
Yes. Dr. Tugal received a total of $48,463 from 32 companies across 188 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Tugal's costs compare to other pediatric hematology & oncology physicians in Hawthorne?
Dr. Tugal's average Medicare payment per service is $107. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Tugal) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →